{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and posted_year = 2008 sorted by posted_date descending", "rows": [["FDA-2007-V-0146-0007", "FDA", "FDA-2007-V-0146", "Acknowledgement Letter to Baylor University", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:33:53Z", null, 0, 0, "09000064807e13b2"], ["FDA-1999-V-4083-0007", "FDA", "FDA-1999-V-4083", "FDA/CDRH Response to United Laser Artists, Inc. - Approval for Variance", "Other", "VRA-Approval for Variance", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:19Z", null, 0, 0, "09000064807e0d82"], ["FDA-2008-P-0343-0013", "FDA", "FDA-2008-P-0343", "Acknowledgement Letter to Novo Nordisk Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:25Z", null, 0, 0, "09000064807f8d4b"], ["FDA-2008-P-0411-0009", "FDA", "FDA-2008-P-0411", "Novo Nordisk Inc. - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-08-11T02:58:51Z", null, 0, 0, "09000064807f9170"], ["FDA-2008-P-0411-0007", "FDA", "FDA-2008-P-0411", "Novo Nordisk Inc. - Petition for Reconsideration", "Other", "PRC-Petition for Reconsideration", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2009-06-18T16:54:55Z", null, 0, 0, "09000064807f8de8"], ["FDA-2008-P-0591-0003", "FDA", "FDA-2008-P-0591", "Regulus Pharmaceutical Consulting, Inc. - Amendment to Citizen Petition", "Other", "AMD-Amendment", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:24Z", null, 0, 0, "09000064807f25fd"], ["FDA-2007-N-0475-0015", "FDA", "FDA-2007-N-0475", "Mylan Pharmaceuticals, Inc. (Mylan) - Letter", "Other", "LET-Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T20:26:19Z", null, 0, 0, "09000064808094ec"], ["FDA-2008-P-0343-0011", "FDA", "FDA-2008-P-0343", "Acknowledgement Letter to Novo Nordisk Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-08-11T04:30:35Z", null, 0, 0, "09000064807f915e"], ["FDA-2008-P-0380-0004", "FDA", "FDA-2008-P-0380", "FDA/CDER Interim Response to National Association of Chain Drug Stores - Letter", "Other", "LET-Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:49Z", null, 0, 0, "09000064808094f2"], ["FDA-2008-P-0343-0012", "FDA", "FDA-2008-P-0343", "Novo Nordisk Inc. - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-08-11T02:58:51Z", null, 0, 0, "09000064807f9130"], ["FDA-1999-V-4083-0003", "FDA", "FDA-1999-V-4083", "FDA/CDRH Response to United Laser Artists, Inc. - Approval for Variance", "Other", "VRA-Approval for Variance", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:14Z", null, 0, 0, "09000064804f5ec4"], ["FDA-1999-V-4083-0004", "FDA", "FDA-1999-V-4083", "United Laser Artists, Inc. Request for Extension of Compliance Date", "Other", "EXP-Request for Extension of Compliance Date", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:15Z", null, 0, 0, "09000064804f5ec5"], ["FDA-2008-P-0660-0001", "FDA", "FDA-2008-P-0660", "OncoTherapies Limited - Citizen Petition", "Other", "CP-Citizen Petition", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:18Z", null, 0, 0, "09000064807eedcc"], ["FDA-2008-P-0660-0002", "FDA", "FDA-2008-P-0660", "Acknowledgement Letter to OncoTherapies Limited", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-08-11T02:58:50Z", null, 0, 0, "09000064807ef0e8"], ["FDA-2008-P-0662-0002", "FDA", "FDA-2008-P-0662", "Acknowledgement Letter to Lachman Consultant Services, Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-08-11T04:30:38Z", null, 0, 0, "09000064808080df"], ["FDA-2007-P-0293-0004", "FDA", "FDA-2007-P-0293", "Letter from David K. Richardson to FDA DMB", "Other", "Letter(s)", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2025-03-11T18:33:37Z", null, 0, 0, "09000064807df592"], ["FDA-1999-V-4083-0005", "FDA", "FDA-1999-V-4083", "FDA/CDRH Response to United Laser Artists, Inc. - Approval for Variance", "Other", "VRA-Approval for Variance", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:16Z", null, 0, 0, "09000064804f5ec6"], ["FDA-1999-V-4083-0002", "FDA", "FDA-1999-V-4083", "Acknowledgement Letter to United Laser Artists, Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:13Z", null, 0, 0, "09000064804f5ec3"], ["FDA-2008-P-0384-0004", "FDA", "FDA-2008-P-0384", "FDA/CVM Interim Response to Laurie Rentas - Letter", "Other", "LET-Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T20:55:39Z", null, 0, 0, "09000064808094ee"], ["FDA-2007-V-0146-0006", "FDA", "FDA-2007-V-0146", "Baylor University - Request for Extension of Compliance Date", "Other", "VAR-Application for Variance", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T19:03:28Z", null, 0, 0, "09000064807e0b96"], ["FDA-2007-N-0475-0009", "FDA", "FDA-2007-N-0475", "FDA/CDER/OGD - \"Response to Midodrine Application Holder\"  - Letter", "Other", "LET-Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2010-08-31T15:00:44Z", null, 0, 0, "0900006480439408"], ["FDA-2008-P-0411-0010", "FDA", "FDA-2008-P-0411", "Acknowledgement Letter to Novo Nordisk Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-28T01:58:06Z", null, 0, 0, "09000064807f8e2e"], ["FDA-2008-P-0411-0008", "FDA", "FDA-2008-P-0411", "Acknowledgement Letter to Novo Nordisk Inc.", "Other", "ACK-Acknowledgement Letter", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:27Z", null, 0, 0, "09000064807f919e"], ["FDA-1999-V-4083-0006", "FDA", "FDA-1999-V-4083", "United Laser Artists, Inc. Request for Extension of Compliance Date", "Other", "EXP-Request for Extension of Compliance Date", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:18Z", null, 0, 0, "0900006480785a13"], ["FDA-2008-D-0053-0158", "FDA", "FDA-2008-D-0053", "Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices\nGuidance for Industry", "Other", "Guidance", "2008-12-31T05:00:00Z", 2008, 12, "2020-05-13T04:00:00Z", null, "2024-11-06T23:36:21Z", null, 1, 0, "09000064845ef064"], ["FDA-2008-P-0662-0001", "FDA", "FDA-2008-P-0662", "Lachman Consultant Services, Inc. - Citizen Petition", "Other", "CP-Citizen Petition", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2024-11-12T04:34:37Z", null, 1, 0, "09000064808080cb"], ["FDA-2008-P-0343-0010", "FDA", "FDA-2008-P-0343", "Novo Nordisk Inc. - Petition for Reconsideration", "Other", "PRC-Petition for Reconsideration", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2009-06-18T16:43:05Z", null, 0, 0, "09000064807f8ce8"], ["FDA-1999-V-4083-0001", "FDA", "FDA-1999-V-4083", "United Laser Artists Inc. - Request for Variance", "Other", "VAR-Application for Variance", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2008-12-31T21:35:11Z", null, 0, 0, "09000064804f5ec2"], ["FDA-2008-P-0197-0004", "FDA", "FDA-2008-P-0197", "FDA Response to William J. Kennick, Esq. - Petition Denial", "Other", "PDN-Petition Denial", "2008-12-31T05:00:00Z", 2008, 12, "2008-12-31T05:00:00Z", null, "2013-07-27T22:34:19Z", null, 0, 0, "09000064807eef30"], ["FDA-2008-P-0531-0129", "FDA", "FDA-2008-P-0531", "Richard F. Edlich, M.D., Ph.D. - (University of Virginia Health System) - Supplement Citizen Petition", "Other", "SUP-Supplement", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2010-04-28T03:55:03Z", null, 0, 0, "09000064807de339"], ["FDA-2008-P-0605-0003", "FDA", "FDA-2008-P-0605", "Woolsthorpe Technologies - Withdrawal of Petition for Reconsideration", "Other", "WDL-Withdrawal", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2008-12-30T22:03:15Z", null, 0, 0, "09000064807e388a"], ["FDA-2008-P-0654-0001", "FDA", "FDA-2008-P-0654", "Procter & Gamble Company - Citizen Petition", "Other", "CP-Citizen Petition", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2013-07-27T22:34:02Z", null, 0, 0, "09000064807e31cc"], ["FDA-2008-P-0584-0002", "FDA", "FDA-2008-P-0584", "Acknowledgement Letter to Cohen, Tauber, Spievack & Wagner P.C.", "Other", "ACK-Acknowledgement Letter", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2008-12-30T16:35:33Z", null, 0, 0, "09000064807a92f0"], ["FDA-1991-P-0058-0003", "FDA", "FDA-1991-P-0058", "FDA/CFSAN Response to Lois M. Meyer - Letter", "Other", "LET-Letter", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2013-07-28T01:58:00Z", null, 0, 0, "09000064807e383a"], ["FDA-2008-N-0523-0005", "FDA", "FDA-2008-N-0523", "Plasma Protein Therapeutics Association (PPTA) - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2013-07-27T22:34:14Z", null, 0, 0, "09000064807e8734"], ["FDA-2008-P-0654-0005", "FDA", "FDA-2008-P-0654", "Tab C - \"FDA Response Letter to Santarus, Inc. Dated June 10, 2004\" - [Proctor and Gamble - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2008-12-30T15:47:01Z", null, 0, 0, "09000064807e323b"], ["FDA-2008-P-0358-0007", "FDA", "FDA-2008-P-0358", "Interim Response Letter from FDA/CDER to James P. Reichmann", "Other", "Letter(s)", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2015-10-08T13:03:39Z", null, 0, 0, "09000064807e37ba"], ["FDA-2008-P-0368-0007", "FDA", "FDA-2008-P-0368", "FDA/CDER Interim Response to ISTA Pharmaceuticals - Letter", "Other", "LET-Letter", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2008-12-31T00:25:10Z", null, 0, 0, "0900006480807c1c"], ["FDA-2008-N-0650-0001", "FDA", "FDA-2008-N-0650", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "N-Notice", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", "2009-03-03T04:59:59Z", "2024-11-12T04:27:47Z", "E8-31058", 1, 0, "09000064808079b5"], ["FDA-1991-P-0058-0004", "FDA", "FDA-1991-P-0058", "Attachment 1 - \"Wonder Stoneground 100% Whole Wheat  Label\" - [Lois Meyer - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2008-12-31T00:00:52Z", null, 0, 0, "09000064807e31a3"], ["FDA-1978-N-0018-0652", "FDA", "FDA-1978-N-0018", "Playtex Products, Inc. Comments to Proposed Monograph for OTC Sunscreen Products re: Comment from Energizer Personal Care (Playtex Products, Inc)", "Supporting & Related Material", "Background Material", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2019-07-29T17:47:16Z", null, 0, 0, "090000648055c1e1"], ["FDA-1991-P-0058-0001", "FDA", "FDA-1991-P-0058", "Lois M. Meyer - Citizen Petition", "Other", "CP-Citizen Petition", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2013-07-28T01:42:43Z", null, 0, 0, "090000648052b9b2"], ["FDA-2008-P-0584-0001", "FDA", "FDA-2008-P-0584", "Cohen, Tauber, Spievack & Wagner P.C - Citizen Petition", "Other", "CP-Citizen Petition", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2011-05-12T19:39:48Z", null, 0, 0, "09000064807a92d0"], ["FDA-2008-P-0654-0002", "FDA", "FDA-2008-P-0654", "Acknowledgement Letter to Procter & Gamble Company", "Other", "ACK-Acknowledgement Letter", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2008-12-30T15:46:18Z", null, 0, 0, "09000064807e32ef"], ["FDA-2008-P-0654-0006", "FDA", "FDA-2008-P-0654", "Tab G - \"CDER OTC Medical Officer's Review\" - [Proctor & Gamble - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2008-12-30T15:47:02Z", null, 0, 0, "09000064807e32d7"], ["FDA-2005-P-0381-0005", "FDA", "FDA-2005-P-0381", "Attachment 2 - Product Description for Diphenoxylate Hydrochloride and Atropin Sulfate Tablets and Oral Solution, 5 mg/0.05 mg re Citizens Petition from Lachman Consultant Services, Inc.", "Supporting & Related Material", "Background Material", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2024-11-12T17:56:32Z", null, 0, 0, "09000064807ddd58"], ["FDA-2007-N-0451-0005", "FDA", "FDA-2007-N-0451", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "N-Notice", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2008-12-30T13:05:40Z", "E8-31057", 0, 0, "09000064808079a6"], ["FDA-2008-P-0654-0003", "FDA", "FDA-2008-P-0654", "Tab A - \"Clinical Review: Division of Gastrointestinal and Coagulation Drug Products\" - [Proctor & Gamble Company - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2008-12-30T15:49:04Z", null, 0, 0, "09000064807e31ff"], ["FDA-2008-P-0654-0004", "FDA", "FDA-2008-P-0654", "Tab B - \"Memorandum - Director (Deputy) Summary Approval Comments NDA 21-636, Dated June 14, 2004\" - [Proctor & Gamble - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2008-12-30T15:48:20Z", null, 0, 0, "09000064807e3227"], ["FDA-1991-P-0058-0002", "FDA", "FDA-1991-P-0058", "Acknowledegement Letter to Lois M. Meyer", "Other", "ACK-Acknowledgement Letter", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2013-07-27T22:34:01Z", null, 0, 0, "09000064807e2f7c"], ["FDA-1978-N-0018-0653", "FDA", "FDA-1978-N-0018", "Supplement from Energizer Personal Care (Playtex Products, Inc.)", "Other", "Supplement (SUP)", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2019-07-31T14:56:45Z", null, 0, 0, "09000064807df3d8"], ["FDA-2006-P-0149-0004", "FDA", "FDA-2006-P-0149", "Citizen Petition from Washington Legal Foundation (WLF)", "Other", "Citizen Petition", "2008-12-30T05:00:00Z", 2008, 12, "2008-12-30T05:00:00Z", null, "2024-11-25T14:15:20Z", null, 1, 0, "09000064804504fa"], ["FDA-2008-N-0039-0092", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - Original Abbreviated New Drug Application - ANADA 200-459", "Supporting & Related Material", "Freedom of Information Summary", "2008-12-29T05:00:00Z", 2008, 12, null, null, "2013-07-09T18:51:04Z", null, 0, 0, "0900006480805f78"], ["FDA-2008-N-0637-0001", "FDA", "FDA-2008-N-0637", "Agency Information Collection Activities; Proposed Collection; Comment Request; Financial Disclosure by Clinical Investigators", "Notice", "N-Notice", "2008-12-29T05:00:00Z", 2008, 12, "2008-12-29T05:00:00Z", "2009-02-28T04:59:59Z", "2024-11-12T04:27:44Z", "E8-30837", 1, 0, "0900006480805ec3"], ["FDA-2008-N-0652-0001", "FDA", "FDA-2008-N-0652", "Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation", "Notice", "N-Notice", "2008-12-29T05:00:00Z", 2008, 12, "2008-12-29T05:00:00Z", "2009-02-28T04:59:59Z", "2024-11-12T04:27:11Z", "E8-30839", 1, 0, "0900006480805e3a"], ["FDA-2008-N-0039-0091", "FDA", "FDA-2008-N-0039", "Ophthalmic and Topical Dosage Form New Animal Drugs; Triamcinolone Cream", "Rule", "Final Rule", "2008-12-29T05:00:00Z", 2008, 12, "2008-12-29T05:00:00Z", null, "2013-07-09T18:48:19Z", "E8-30694", 0, 0, "0900006480805eeb"], ["FDA-2008-P-0647-0003", "FDA", "FDA-2008-P-0647", "Attachment 1 - Clinoril\u00ae (Sulindac, 200mg Tablets) Product Description - [Lachman Consultant Services, Inc. - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-24T05:00:00Z", 2008, 12, null, null, "2008-12-24T15:06:35Z", null, 0, 0, "09000064807d93bb"], ["FDA-2008-S-0350-0002", "FDA", "FDA-2008-S-0350", "Public Submissions without Docket Number or ID", "Other", "SPE-No Docket ID", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", null, "2008-12-24T18:04:47Z", null, 0, 0, "09000064806279a5"], ["FDA-2005-P-0134-0004", "FDA", "FDA-2005-P-0134", "Petition Denial from FDA CDER to Lachman Consultant Services, Inc.", "Other", "PDN-Petition Denial", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", null, "2024-11-12T18:26:40Z", null, 0, 0, "09000064807dcaef"], ["FDA-2005-P-0134-0003", "FDA", "FDA-2005-P-0134", "Citizens Petition from Lachman Consultant Services, Inc.", "Other", "CP-Citizen Petition", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", null, "2024-11-12T18:24:31Z", null, 0, 0, "090000648043fe1e"], ["FDA-2006-P-0007-0022", "FDA", "FDA-2006-P-0007", "See Document ID FDA-2008-D-0626-0002 re Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl Notice of Availability  Reference", "Supporting & Related Material", "REF-Reference Material (external attachments)", "2008-12-24T05:00:00Z", 2008, 12, null, null, "2014-02-01T00:56:34Z", null, 0, 0, "09000064807f2141"], ["FDA-2005-P-0381-0004", "FDA", "FDA-2005-P-0381", "Petition Denial from FDA CDER to Lachman Consultant Services, Inc.", "Other", "PDN-Petition Denial", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", null, "2024-11-12T17:54:02Z", null, 0, 0, "09000064807dcb48"], ["FDA-2005-P-0134-0005", "FDA", "FDA-2005-P-0134", "Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations (Electronic Orange Book), April 25, 2005 re Citizens Petition from Lachman Consultant Services, Inc.", "Supporting & Related Material", "Background Material", "2008-12-24T05:00:00Z", 2008, 12, null, null, "2024-11-12T18:30:08Z", null, 0, 0, "09000064807f8ef6"], ["FDA-2008-P-0647-0004", "FDA", "FDA-2008-P-0647", "Attachment 2 - Product Description - Sulindac Capsules (Sulindac) - [Lachman Consultant Services, Inc. - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-24T05:00:00Z", 2008, 12, null, null, "2008-12-24T15:06:37Z", null, 0, 0, "09000064807d93dc"], ["FDA-2008-P-0647-0005", "FDA", "FDA-2008-P-0647", "Attachment 3 - Approved Drug Products with Therapeutic Equivalence Evaluations, 28th Edition - [Lachman Consultant Services, Inc. - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2008-12-24T05:00:00Z", 2008, 12, null, null, "2008-12-24T15:06:38Z", null, 0, 0, "09000064807d9426"], ["FDA-2008-S-0350-0001", "FDA", "FDA-2008-S-0350", "Food Additives Permitted in Feed and Drinking Water of Animals", "Rule", "NCR-Notice of Correction", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", null, "2008-12-24T17:44:31Z", "E8-30840", 0, 0, "09000064807f8dc4"], ["FDA-2008-N-0045-0008", "FDA", "FDA-2008-N-0045", "Regulatory Site Visit Training Program; December 24, 2008", "Notice", "N-Notice", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", "2009-01-24T04:59:59Z", "2010-03-26T22:43:43Z", "E8-30659", 0, 0, "09000064807f8e05"], ["FDA-2005-P-0381-0003", "FDA", "FDA-2005-P-0381", "Citizens Petition from Lachman Consultant Services, Inc.", "Other", "CP-Citizen Petition", "2008-12-24T05:00:00Z", 2008, 12, "2008-12-24T05:00:00Z", null, "2024-11-12T17:52:49Z", null, 0, 0, "090000648044bec6"], ["FDA-1994-N-0182-0048", "FDA", "FDA-1994-N-0182", "Transcript of the Pubic Hearing on Acyclovir - Transcript", "Other", "TR-Transcript", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:45Z", null, 0, 0, "090000648070b75e"], ["FDA-1994-N-0182-0009", "FDA", "FDA-1994-N-0182", "FDA \"Dear Colleague\" Letter", "Other", "LET-Letter", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:01Z", null, 0, 0, "090000648050714a"], ["FDA-1994-N-0182-0027", "FDA", "FDA-1994-N-0182", "Harvard Medical School - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:21Z", null, 0, 0, "0900006480507164"], ["FDA-1994-N-0182-0022", "FDA", "FDA-1994-N-0182", "Association of Reproductive Professional - Supplement", "Other", "SUP-Supplement", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:15Z", null, 0, 0, "090000648050715e"], ["FDA-1994-N-0182-0005", "FDA", "FDA-1994-N-0182", "Distribution of FR Notice for Acyclovir Public Hearing - Memorandum", "Other", "M-Memorandum", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:00:57Z", null, 0, 0, "0900006480507146"], ["FDA-1994-N-0182-0040", "FDA", "FDA-1994-N-0182", "American Social Health Association - Testimony", "Other", "TS-Testimony", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-08-11T02:40:17Z", null, 0, 0, "0900006480507187"], ["FDA-1978-N-0018-0644", "FDA", "FDA-1978-N-0018", "Citizen Petition from The International Center for Technology Assessment", "Other", "Citizen Petition", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2019-07-31T18:01:58Z", null, 0, 0, "090000648055a922"], ["FDA-1978-N-0018-0648", "FDA", "FDA-1978-N-0018", "Acknowledgment Letter from FDA to Ciba Corporation", "Other", "Acknowledgement Letter/Receipt", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2019-07-30T16:41:18Z", null, 0, 0, "09000064807d5c45"], ["FDA-1978-N-0018-0646", "FDA", "FDA-1978-N-0018", "Citizen Petition from Ciba Corporation", "Other", "Citizen Petition", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2019-08-02T01:01:01Z", null, 0, 0, "09000064807d5b6c"], ["FDA-1994-N-0182-0003", "FDA", "FDA-1994-N-0182", "FDA \"Dear Colleague\" Letter", "Other", "LET-Letter", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:00:54Z", null, 0, 0, "0900006480507144"], ["FDA-1994-N-0182-0046", "FDA", "FDA-1994-N-0182", "HFD-9 - Memorandum", "Other", "M-Memorandum", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:43Z", null, 0, 0, "09000064805071be"], ["FDA-1994-N-0182-0013", "FDA", "FDA-1994-N-0182", "Denise M. Buntin, M.D. - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-08-11T02:40:16Z", null, 0, 0, "0900006480507150"], ["FDA-1994-N-0182-0020", "FDA", "FDA-1994-N-0182", "American Academy of Dermatology - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "090000648050715a"], ["FDA-1994-N-0182-0031", "FDA", "FDA-1994-N-0182", "Nonprescription Drug Manufacturers Assn. - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:26Z", null, 0, 0, "090000648050716f"], ["FDA-1994-N-0182-0030", "FDA", "FDA-1994-N-0182", "Center for Disease Control and Prevention - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:25Z", null, 0, 0, "090000648050716e"], ["FDA-2004-D-0375-0019", "FDA", "FDA-2004-D-0375", "Guidance for Industry and Food and Drug Administration Staff; ``Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300; Availability", "Notice", "NAD-Notice of Availability of Data", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T12:40:16Z", "E8-30586", 0, 0, "09000064807eda05"], ["FDA-2008-N-0644-0001", "FDA", "FDA-2008-N-0644", "SEQC--The Sequencing Quality Control Project", "Notice", "N-Notice", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T12:54:12Z", "E8-30410", 0, 0, "09000064807eda32"], ["FDA-1994-N-0182-0049", "FDA", "FDA-1994-N-0182", "Index - List", "Other", "LST-List", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:47Z", null, 0, 0, "090000648070b89e"], ["FDA-1978-N-0018-0645", "FDA", "FDA-1978-N-0018", "Citizen Petition from Schering-Plough Corporation", "Other", "Citizen Petition", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2019-07-30T16:47:54Z", null, 0, 0, "090000648055aa39"], ["FDA-1994-N-0182-0018", "FDA", "FDA-1994-N-0182", "National Women's Health Network - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "0900006480507156"], ["FDA-1994-N-0182-0026", "FDA", "FDA-1994-N-0182", "Infectious Diseases Society of America - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:20Z", null, 0, 0, "0900006480507163"], ["FDA-1994-N-0182-0007", "FDA", "FDA-1994-N-0182", "Distribution of FR Notice for Acyclovir Public Hearing - Memorandum", "Other", "M-Memorandum", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:00:59Z", null, 0, 0, "0900006480507148"], ["FDA-1994-N-0182-0006", "FDA", "FDA-1994-N-0182", "FDA \"Dear Colleague\" Letter", "Other", "LET-Letter", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:00:58Z", null, 0, 0, "0900006480507147"], ["FDA-1994-N-0182-0044", "FDA", "FDA-1994-N-0182", "Harvard Medical School - Letter", "Other", "LET-Letter", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:41Z", null, 0, 0, "09000064805071aa"], ["FDA-1994-N-0182-0019", "FDA", "FDA-1994-N-0182", "University of Kansas Medical Center - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "0900006480507157"], ["FDA-1994-N-0182-0015", "FDA", "FDA-1994-N-0182", "The Center for Proper Medication Use - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "0900006480507152"], ["FDA-1994-N-0182-0042", "FDA", "FDA-1994-N-0182", "HFD-336 - Memorandum", "Other", "M-Memorandum", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:39Z", null, 0, 0, "0900006480507198"], ["FDA-1994-N-0182-0017", "FDA", "FDA-1994-N-0182", "University of Pittsburgh - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "0900006480507154"], ["FDA-1994-N-0182-0032", "FDA", "FDA-1994-N-0182", "Denise M. Buntin, M.D., P.C - Wthdrawal", "Other", "WDL-Withdrawal", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "0900006480507171"], ["FDA-1994-N-0182-0021", "FDA", "FDA-1994-N-0182", "Infectious Diseases Society for Ob-Gyn - Appearance Request", "Other", "APE-Appearance Request", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2013-07-27T21:20:30Z", null, 0, 0, "090000648050715b"], ["FDA-1994-N-0182-0033", "FDA", "FDA-1994-N-0182", "HFD-9 - List", "Other", "LST-List", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", null, "2008-12-23T21:01:29Z", null, 0, 0, "0900006480507173"], ["FDA-2008-N-0648-0001", "FDA", "FDA-2008-N-0648", "Agency Information Collection Activities; Proposed Collection; Comment Request; PDUFA Pilot Project Proprietary Name Review", "Notice", "N-Notice", "2008-12-23T05:00:00Z", 2008, 12, "2008-12-23T05:00:00Z", "2009-02-24T04:59:59Z", "2008-12-23T12:59:23Z", "E8-30587", 0, 0, "09000064807eda6f"]], "truncated": false, "filtered_table_rows_count": 5759, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "2008"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2008", "results": [{"value": "FDA", "label": "FDA", "count": 5759, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?posted_year=2008", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2008", "results": [{"value": "Other", "label": "Other", "count": 3534, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 1492, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 607, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&document_type=Notice", "selected": false}, {"value": "Rule", "label": "Rule", "count": 101, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&document_type=Rule", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2008", "results": [{"value": 2008, "label": 2008, "count": 5759, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_facet_date=last_modified"}], "next": "2008-12-23T05~3A00~3A00Z,FDA-2008-N-0648-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2008&_next=2008-12-23T05~3A00~3A00Z%2CFDA-2008-N-0648-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 970.3777390532196, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}